Groff North America, in Red Lion, PA, is pleased to be in the position of being a Schedule 1 bulk manufacturers of cannabis authorized by the U.S. Drug Enforcement Administration (DEA). Groff North America was awarded an extensive suite of Schedule 1 DEA registrations in 2021 including import, export, bulk manufacturing, patient dosed, and analytical laboratory. All cannabis preparations (manicured flower, cannabis extracts, cannabinoid isolates, etc.) are manufactured to the highest standards in our DEA-approved, Schedule 1 facility. All products undergo extensive testing both in our internal Schedule 1 registered analytical lab and through third party ISO Accredited Laboratories. Through a combination of technology and human capital, we continue to develop innovative and proven products for our customers.